English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  52803648    Online Users :  616
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"hsu c"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 466-475 of 881  (89 Page(s) Totally)
<< < 42 43 44 45 46 47 48 49 50 51 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-09-22T07:39:54Z Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil Chao-Yu Hsu ;Shen Y.-C. ;Yu C.-W. ;Hsu C. ;Hu F.-C. ;Hsu C.-H. ;Chen B.-B. ;Wei S.-Y. ;Cheng A.-L. ;Shih T.T.-F.; CHAO-YU HSU; Shen Y.-C.; Yu C.-W.; Hsu C.; Hu F.-C.; Hsu C.-H.; Chen B.-B.; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F.
臺大學術典藏 2020-09-22T07:39:51Z Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy Shih T.T.-F.; Cheng A.-L.; Hsu C.-H.; Hsu C.; Liang P.-C.; Chen B.-B.; CHAO-YU HSU; Yu C.-W.
臺大學術典藏 2020-09-22T07:39:50Z Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma Chen B.-B.;Chao-Yu Hsu;Yu C.-W.;Liang P.-C.;Hsu C.;Hsu C.-H.;Cheng A.-L.;Shih T.T.-F.; Chen B.-B.; CHAO-YU HSU; Yu C.-W.; Liang P.-C.; Hsu C.; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F.
臺大學術典藏 2020-08-14T03:15:33Z Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies Chen B.-B.; I-LUN SHIH; Wu C.-H.; Hsu C.; Chen C.-H.; Shih T.T.-F.; Liu K.-L.; Liang P.-C.
臺大學術典藏 2020-08-14T03:15:30Z Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; I-LUN SHIH; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-08-13T06:34:06Z Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status Su W.-P.; Yang C.-H.; Yu C.-J.; JIN-YUAN SHIH; Hsu C.; Yang P.-C.; Su W.-P.;Yang C.-H.;Yu C.-J.;Jin-Yuan Shih;Hsu C.;Yang P.-C.
臺大學術典藏 2020-08-13T06:34:05Z Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer Lin C.-P.; Su W.-P.; Gow C.-H.; Hsu C.; Chang G.-C.; Yang P.-C.; Yu C.-J.; Yang T.-Y.; Yang C.-H.; JIN-YUAN SHIH; Chen K.-C.
臺大學術典藏 2020-08-13T06:33:59Z Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial Yang C.-H.; Yang P.-C.; Huang T.-C.; Lin C.-C.; Yu C.-J.; Hsu C.; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; JIN-YUAN SHIH
臺大學術典藏 2020-08-12T06:35:54Z Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials CHONG-JEN YU; Hsu C.; Cheng A.-L.; Yang P.-C.; Kuo S.-H.; Yang C.-H.; Kuo S.-H.;Yang C.-H.;Chong-Jen Yu;Hsu C.;Cheng A.-L.;Yang P.-C.
臺大學術典藏 2020-08-12T06:35:50Z Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status Su W.-P.;Yang C.-H.;Chong-Jen Yu;Shih J.-Y.;Hsu C.;Yang P.-C.; Su W.-P.; Yang C.-H.; CHONG-JEN YU; Shih J.-Y.; Hsu C.; Yang P.-C.

Showing items 466-475 of 881  (89 Page(s) Totally)
<< < 42 43 44 45 46 47 48 49 50 51 > >>
View [10|25|50] records per page